Southern RNA is a pioneering Australian contract development and manufacturing organisation (CDMO) specialising in RNA-based therapeutics and vaccines. With facilities in Brisbane and R&D labs within the Gold Coast Health and Knowledge Precinct, they provide end-to-end services for mRNA and plasmid DNA production, supporting clients from early-stage research to clinical trials.
Key Highlights:
-
End-to-End RNA Manufacturing: Offering comprehensive services from construct design to GMP-grade mRNA and plasmid DNA production, including analytical testing and quality control.
-
Innovative Products: Developed Co Cap™ A, a co-transcriptional capping reagent enhancing mRNA stability and translational efficiency.
-
Collaborative Ecosystem: Secured a $5 million Medical Research Future Fund (MRFF) grant to establish an mRNA translation ecosystem in Queensland, fostering partnerships with academic and industry stakeholders.
Southern RNA’s integration within the Gold Coast Health and Knowledge Precinct underscores its commitment to advancing RNA technologies and contributing to Australia’s biomanufacturing capabilities.
